---
date: 2022-08-10
title: |
  Efficacy and safety of the investigational complement C5 inhibitor zilucoplan
  in patients hospitalized with COVID-19: an open-label randomized controlled
  trial (no authoring)
draft: false
image: https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12931-022-02126-2/MediaObjects/12931_2022_2126_Fig2_HTML.png?as=webp#_s_
showonlyimage: false
weight: -220810
---

Title: _Efficacy and safety of the investigational complement C5 inhibitor
 zilucoplan in patients hospitalized with COVID-19: an open-label randomized
controlled trial_

[`DOI:10.1186/s12931-022-02126-2`](https://doi.org/10.1186/s12931-022-02126-2)

2022-10-08

<!--more-->

This was a public outcome of my involvement at UCB.
I won't go further in the presentation of the paper since I don't endorse
authorship for this work, my technical contribution was simply acknowledged for
the visual output below.

![](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12931-022-02126-2/MediaObjects/12931_2022_2126_Fig2_HTML.png?as=webp)

[modeline]: # ( vim: set foldlevel=0 spell spelllang=en_gb: )
